|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000026025 |
Summary for VIM |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000026025 | Gene symbol | VIM |
| Gene name | vimentin | |
| HGNC | 12692 | |
| Entrez ID | 7431 | |
| Gene type | protein_coding | |
| Synonyms | VIM| | |
| UniProtAcc | P08670 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000026025 | VIM | DB11638 | Artenimol | SmallMoleculeDrug |
| ENSG00000026025 | VIM | DB12695 | Phenethyl Isothiocyanate | SmallMoleculeDrug |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for VIM |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| VIM | 2.34e+04 | -1.07e+00 | 4.64e-01 | -2.31e+00 | 2.07e-02 | 4.44e-02 | BLCA |
| VIM | 4.19e+04 | 2.25e+00 | 6.35e-01 | 3.55e+00 | 3.92e-04 | 1.48e-03 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| VIM | 1.73e+04 | -1.42e+00 | 2.89e-01 | -4.90e+00 | 9.61e-07 | 3.61e-06 | KICH |
| VIM | 6.18e+04 | -1.41e+00 | 8.79e-02 | -1.60e+01 | 6.80e-58 | 8.64e-57 | BRCA |
| VIM | 9.93e+03 | -1.02e+00 | 3.50e-01 | -2.92e+00 | 3.50e-03 | 1.02e-02 | READ |
Top |
Sex-biased somatic mutation for VIM |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for VIM |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg12874092 | chr10:17229520 | CGI:chr10:17228431-17230618 | promoter,exon,CDS,gene body | 1.83e-01 | 3.34e-01 | -1.98e+00 | 4.82e-02 | 4.92e-02 | -1.51e-01 |
| BRCA | cg19111999 | chr10:17228088 | CGI:chr10:17228431-17230618 | promoter | 3.64e-01 | 5.79e-01 | -2.65e+00 | 8.04e-03 | 2.46e-02 | -2.16e-01 |
| BRCA | cg20198108 | chr10:17228092 | CGI:chr10:17228431-17230618 | promoter | 2.58e-01 | 4.12e-01 | -2.23e+00 | 2.54e-02 | 3.83e-02 | -1.54e-01 |
| BRCA | cg05151811 | chr10:17228251 | CGI:chr10:17228431-17230618 | promoter | 2.61e-01 | 4.43e-01 | -2.38e+00 | 1.73e-02 | 3.31e-02 | -1.82e-01 |
| BRCA | cg08918274 | chr10:17228301 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 3.01e-01 | 4.97e-01 | -2.32e+00 | 2.02e-02 | 3.51e-02 | -1.96e-01 |
| BRCA | cg23912429 | chr10:17228432 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 3.52e-01 | 5.41e-01 | -2.11e+00 | 3.48e-02 | 4.35e-02 | -1.89e-01 |
| BRCA | cg11973177 | chr10:17229007 | CGI:chr10:17228431-17230618 | promoter,exon,gene body | 1.62e-01 | 2.68e-01 | -2.17e+00 | 3.00e-02 | 4.10e-02 | -1.05e-01 |
| BRCA | cg26983469 | chr10:17229052 | CGI:chr10:17228431-17230618 | promoter,gene body | 2.67e-01 | 4.26e-01 | -2.17e+00 | 2.98e-02 | 4.08e-02 | -1.59e-01 |
| SARC | cg10790685 | chr10:17227275 | CGI:chr10:17228431-17230618 | promoter | 4.39e-01 | 5.60e-01 | -2.91e+00 | 3.65e-03 | 9.17e-03 | -1.22e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg10790685 | chr10:17227275 | CGI:chr10:17228431-17230618 | promoter | 4.00e-01 | 5.21e-01 | -3.24e+00 | 1.19e-03 | 2.25e-03 | -1.20e-01 |
| LUAD | cg26983469 | chr10:17229052 | CGI:chr10:17228431-17230618 | promoter,gene body | 1.54e-01 | 4.91e-02 | 2.35e+00 | 1.90e-02 | 2.27e-02 | 1.05e-01 |
| THCA | cg10790685 | chr10:17227275 | CGI:chr10:17228431-17230618 | promoter | 6.04e-01 | 4.81e-01 | 2.42e+00 | 1.54e-02 | 2.24e-02 | 1.23e-01 |
| HNSC | cg27313572 | chr10:17229295 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 1.34e-01 | 1.76e-02 | 4.74e+00 | 2.12e-06 | 1.06e-05 | 1.17e-01 |
| HNSC | cg23991622 | chr10:17229304 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 1.39e-01 | 2.41e-02 | 3.63e+00 | 2.85e-04 | 6.26e-04 | 1.15e-01 |
| LUSC | cg02236650 | chr10:17227776 | CGI:chr10:17228431-17230618 | promoter | 3.14e-01 | 1.11e-01 | 3.18e+00 | 1.48e-03 | 3.38e-03 | 2.04e-01 |
| COAD | cg01003015 | chr10:17229137 | CGI:chr10:17228431-17230618 | promoter,gene body | 1.97e-01 | 7.50e-02 | 3.52e+00 | 4.33e-04 | 1.14e-03 | 1.22e-01 |
| COAD | cg08918274 | chr10:17228301 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 1.66e-01 | 5.21e-02 | 1.97e+00 | 4.93e-02 | 4.94e-02 | 1.14e-01 |
| BLCA | cg02746869 | chr10:17229930 | CGI:chr10:17228431-17230618 | promoter,exon,CDS,gene body | 3.67e-01 | 9.83e-02 | 2.79e+00 | 5.24e-03 | 8.45e-03 | 2.69e-01 |
| BLCA | cg18514820 | chr10:17229945 | CGI:chr10:17228431-17230618 | promoter,exon,CDS,gene body | 3.91e-01 | 7.29e-02 | 2.81e+00 | 4.94e-03 | 8.07e-03 | 3.18e-01 |
| BLCA | cg20319091 | chr10:17229995 | CGI:chr10:17228431-17230618 | promoter,gene body | 2.80e-01 | 3.54e-02 | 2.90e+00 | 3.73e-03 | 6.44e-03 | 2.45e-01 |
| BLCA | cg05151811 | chr10:17228251 | CGI:chr10:17228431-17230618 | promoter | 2.41e-01 | 7.77e-02 | 2.59e+00 | 9.47e-03 | 1.35e-02 | 1.64e-01 |
| BLCA | cg08918274 | chr10:17228301 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 3.22e-01 | 8.71e-02 | 2.57e+00 | 1.02e-02 | 1.44e-02 | 2.35e-01 |
| BLCA | cg00146951 | chr10:17228377 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 2.54e-01 | 8.63e-02 | 2.40e+00 | 1.62e-02 | 2.07e-02 | 1.68e-01 |
| LIHC | cg01154046 | chr10:17228602 | CGI:chr10:17228431-17230618 | promoter,exon,gene body | 2.04e-01 | 2.40e-02 | 4.17e+00 | 3.08e-05 | 7.31e-05 | 1.80e-01 |
| LIHC | cg23821329 | chr10:17227644 | CGI:chr10:17228431-17230618 | promoter | 2.14e-01 | 5.16e-01 | -5.46e+00 | 4.73e-08 | 2.83e-07 | -3.01e-01 |
| LIHC | cg19111999 | chr10:17228088 | CGI:chr10:17228431-17230618 | promoter | 3.42e-01 | 1.76e-01 | 3.16e+00 | 1.57e-03 | 2.37e-03 | 1.67e-01 |
| LIHC | cg20198108 | chr10:17228092 | CGI:chr10:17228431-17230618 | promoter | 2.66e-01 | 1.01e-01 | 4.05e+00 | 5.23e-05 | 1.17e-04 | 1.65e-01 |
| LIHC | cg06460869 | chr10:17228095 | CGI:chr10:17228431-17230618 | promoter | 3.02e-01 | 1.32e-01 | 4.59e+00 | 4.48e-06 | 1.36e-05 | 1.69e-01 |
| LIHC | cg05151811 | chr10:17228251 | CGI:chr10:17228431-17230618 | promoter | 2.28e-01 | 1.16e-01 | 2.61e+00 | 9.06e-03 | 1.12e-02 | 1.12e-01 |
| LIHC | cg00146951 | chr10:17228377 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 2.80e-01 | 1.65e-01 | 2.31e+00 | 2.11e-02 | 2.34e-02 | 1.14e-01 |
| KIRP | cg23821329 | chr10:17227644 | CGI:chr10:17228431-17230618 | promoter | 3.80e-01 | 5.94e-01 | -3.33e+00 | 8.69e-04 | 1.62e-03 | -2.14e-01 |
| CHOL | cg20018469 | chr10:17230118 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 3.24e-02 | 1.49e-01 | -3.54e+00 | 4.02e-04 | 8.32e-03 | -1.17e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg02746869 | chr10:17229930 | CGI:chr10:17228431-17230618 | promoter,exon,CDS,gene body | 1.88e-01 | 5.13e-02 | 5.21e+00 | 1.87e-07 | 3.72e-07 | 1.36e-01 |
| BRCA | cg18514820 | chr10:17229945 | CGI:chr10:17228431-17230618 | promoter,exon,CDS,gene body | 1.97e-01 | 3.43e-02 | 4.70e+00 | 2.57e-06 | 4.59e-06 | 1.63e-01 |
| BRCA | cg20319091 | chr10:17229995 | CGI:chr10:17228431-17230618 | promoter,gene body | 1.33e-01 | 2.19e-02 | 6.09e+00 | 1.10e-09 | 2.67e-09 | 1.11e-01 |
| BRCA | cg01154046 | chr10:17228602 | CGI:chr10:17228431-17230618 | promoter,exon,gene body | 1.16e-01 | 1.61e-02 | 6.80e+00 | 1.03e-11 | 2.93e-11 | 1.00e-01 |
| BRCA | cg27313572 | chr10:17229295 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 1.57e-01 | 2.05e-02 | 8.04e+00 | 9.36e-16 | 3.61e-15 | 1.36e-01 |
| BRCA | cg23991622 | chr10:17229304 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 1.46e-01 | 2.82e-02 | 7.33e+00 | 2.23e-13 | 7.21e-13 | 1.18e-01 |
| BRCA | cg12874092 | chr10:17229520 | CGI:chr10:17228431-17230618 | promoter,exon,CDS,gene body | 1.83e-01 | 1.47e-02 | 9.71e+00 | 2.64e-22 | 1.74e-21 | 1.68e-01 |
| BRCA | cg10790685 | chr10:17227275 | CGI:chr10:17228431-17230618 | promoter | 4.06e-01 | 5.95e-01 | -8.62e+00 | 6.76e-18 | 3.08e-17 | -1.89e-01 |
| BRCA | cg02236650 | chr10:17227776 | CGI:chr10:17228431-17230618 | promoter | 5.50e-01 | 2.32e-01 | 7.54e+00 | 4.55e-14 | 1.55e-13 | 3.18e-01 |
| BRCA | cg19111999 | chr10:17228088 | CGI:chr10:17228431-17230618 | promoter | 3.64e-01 | 1.54e-01 | 7.10e+00 | 1.26e-12 | 3.83e-12 | 2.10e-01 |
| BRCA | cg20198108 | chr10:17228092 | CGI:chr10:17228431-17230618 | promoter | 2.58e-01 | 1.12e-01 | 4.48e+00 | 7.50e-06 | 1.27e-05 | 1.46e-01 |
| BRCA | cg05151811 | chr10:17228251 | CGI:chr10:17228431-17230618 | promoter | 2.61e-01 | 6.71e-02 | 1.01e+01 | 8.27e-24 | 6.28e-23 | 1.94e-01 |
| BRCA | cg08918274 | chr10:17228301 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 3.01e-01 | 6.81e-02 | 8.83e+00 | 1.09e-18 | 5.28e-18 | 2.33e-01 |
| BRCA | cg00146951 | chr10:17228377 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 2.73e-01 | 7.42e-02 | 1.07e+01 | 6.95e-27 | 7.11e-26 | 1.98e-01 |
| BRCA | cg23912429 | chr10:17228432 | CGI:chr10:17228431-17230618 | UTR,promoter,exon,gene body | 3.52e-01 | 9.29e-02 | 9.40e+00 | 5.29e-21 | 3.12e-20 | 2.60e-01 |
| BRCA | cg11973177 | chr10:17229007 | CGI:chr10:17228431-17230618 | promoter,exon,gene body | 1.62e-01 | 5.92e-02 | 3.39e+00 | 6.89e-04 | 9.24e-04 | 1.03e-01 |
| BRCA | cg26983469 | chr10:17229052 | CGI:chr10:17228431-17230618 | promoter,gene body | 2.67e-01 | 6.00e-02 | 7.91e+00 | 2.63e-15 | 9.81e-15 | 2.07e-01 |
| BLCA | cg02236650 | chr10:17227776 | CGI:chr10:17228431-17230618 | promoter | 4.68e-01 | 2.04e-01 | 2.46e+00 | 1.38e-02 | 2.14e-02 | 2.64e-01 |
Top |
Exon skipping events with PSI in TCGA for VIM |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for VIM |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for VIM |
| TFs related to VIM. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| VIM related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for VIM |
| RBPs related to ES in VIM. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| UVM | MSI1 | exon_skip_39933 | 1.52e+01 | 4.85e-04 | 1.58e+01 | 9.99e-01 | Female-biased |
| THYM | MSI1 | exon_skip_39933 | 1.59e+01 | 9.99e-01 | 1.53e+01 | 4.76e-04 | Male-biased |
| LIHC | MSI1 | exon_skip_39933 | 1.55e+01 | 9.97e-01 | 1.49e+01 | 2.62e-03 | Male-biased |
| LUSC | NOVA2 | exon_skip_39928 | 7.27e+00 | 8.36e-03 | 7.65e+00 | 9.82e-01 | Female-biased |
| DLBC | ENOX1 | exon_skip_39915 | 9.44e+00 | 1.03e-02 | 9.78e+00 | 9.87e-01 | Female-biased |
| LUAD | MSI1 | exon_skip_39933 | 1.44e+01 | 6.67e-04 | 1.51e+01 | 9.99e-01 | Female-biased |
| CHOL | ENOX1 | exon_skip_39915 | 9.73e+00 | 9.88e-01 | 9.32e+00 | 9.69e-03 | Male-biased |
| BRCA | ENOX1 | exon_skip_39915 | 9.69e+00 | 9.83e-01 | 9.17e+00 | 1.49e-02 | Male-biased |
| BRCA | MSI1 | exon_skip_39933 | 1.53e+01 | 9.85e-01 | 1.48e+01 | 1.53e-02 | Male-biased |
| ESCA | RBM6 | exon_skip_39942 | 9.41e+00 | 1.01e-02 | 9.85e+00 | 9.88e-01 | Female-biased |
| READ | MSI1 | exon_skip_39933 | 1.58e+01 | 1.00e+00 | 1.51e+01 | 3.97e-04 | Male-biased |
| LGG | MSI1 | exon_skip_39933 | 1.45e+01 | 1.03e-03 | 1.51e+01 | 9.99e-01 | Female-biased |
| PAAD | MSI1 | exon_skip_39933 | 1.53e+01 | 1.00e+00 | 1.46e+01 | 1.10e-04 | Male-biased |
| BLCA | MSI1 | exon_skip_39933 | 1.50e+01 | 5.02e-04 | 1.57e+01 | 9.99e-01 | Female-biased |
| HNSC | Fusip1 | exon_skip_39936 | 7.00e+00 | 7.76e-03 | 7.35e+00 | 9.81e-01 | Female-biased |
| SARC | MSI1 | exon_skip_39933 | 1.50e+01 | 8.90e-04 | 1.57e+01 | 9.99e-01 | Female-biased |
| VIM related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12250946 | chr10:25134771:C:T | - | 0.1301969839046 | 0.0230385971088763 | PCPG | Female-baised eQTL |
| rs12413226 | chr10:25138529:G:A | - | 0.1301969839046 | 0.0230385971088763 | PCPG | Female-baised eQTL |
| rs12258602 | chr10:25134736:T:C | - | 0.129462748334597 | 0.026253687669831 | PCPG | Female-baised eQTL |
| rs11014409 | chr10:25135253:G:A | - | 0.129462748334597 | 0.026253687669831 | PCPG | Female-baised eQTL |
| rs12240931 | chr10:25152806:G:A | - | 0.12210081634909 | 0.0462382697137249 | PCPG | Female-baised eQTL |
| rs12267845 | chr10:25154636:T:C | - | 0.12210081634909 | 0.0462382697137249 | PCPG | Female-baised eQTL |
| rs7904193 | chr10:25157316:C:T | - | 0.12210081634909 | 0.0462382697137249 | PCPG | Female-baised eQTL |
| rs12246406 | chr10:25142884:C:T | - | 0.121894852351609 | 0.0482183776663356 | PCPG | Female-baised eQTL |
| rs7893138 | chr10:13670701:G:T | - | -0.146229922674447 | 0.0479276139058235 | HNSC | Female-baised eQTL |
| rs11012179 | chr10:20594839:G:C | - | 0.118651344298716 | 0.0121688856396014 | LUSC | Female-baised eQTL |
| rs12359925 | chr10:20597713:G:C | - | 0.115986943049331 | 0.0161297825730483 | LUSC | Female-baised eQTL |
| rs72791262 | chr10:20532595:C:T | - | 0.123301476565407 | 0.0413073420203475 | LUSC | Female-baised eQTL |
| rs10741057 | chr10:18427174:C:A | - | -0.0808575951766087 | 0.021524495506999 | LGG | Female-baised eQTL |
| rs10741058 | chr10:18427216:T:C | - | -0.0810571314722608 | 0.0226593974670206 | LGG | Female-baised eQTL |
| rs997264 | chr10:18414966:C:A | - | -0.0797225913426106 | 0.0327584462704591 | LGG | Female-baised eQTL |
| rs6482408 | chr10:18426611:A:G | - | -0.0784783930116246 | 0.0342936882099244 | LGG | Female-baised eQTL |
| rs6482409 | chr10:18426660:C:T | - | -0.0784783930116246 | 0.0342936882099244 | LGG | Female-baised eQTL |
| rs6482410 | chr10:18426681:A:G | - | -0.0784783930116246 | 0.0342936882099244 | LGG | Female-baised eQTL |
| rs10764483 | chr10:18427417:A:G | - | -0.0784783930116246 | 0.0342936882099244 | LGG | Female-baised eQTL |
| rs10828679 | chr10:18422359:G:A | - | -0.0743787070571933 | 0.0444276306673742 | LGG | Female-baised eQTL |
| rs17267324 | chr10:14723577:G:C | - | 0.153085665273074 | 0.0189302484014625 | KIRC | Female-baised eQTL |
| rs56159005 | chr10:14714418:A:G | - | 0.155587293270729 | 0.0260184490028571 | KIRC | Female-baised eQTL |
| rs111283074 | chr10:14718522:C:T | - | 0.155587293270729 | 0.0260184490028571 | KIRC | Female-baised eQTL |
| rs2167708 | chr10:14719637:C:T | - | 0.155587293270729 | 0.0260184490028571 | KIRC | Female-baised eQTL |
| rs55954679 | chr10:14703140:A:G | - | 0.152134520719397 | 0.027396938845228 | KIRC | Female-baised eQTL |
| rs7918691 | chr10:9497083:G:A | - | -0.0705409275013456 | 0.0406611551382592 | KIRC | Female-baised eQTL |
| rs113072550 | chr10:14725986:C:T | - | 0.147335040796715 | 0.0415772131625416 | KIRC | Female-baised eQTL |
| rs76882717 | chr10:14726308:C:T | - | 0.147335040796715 | 0.0415772131625416 | KIRC | Female-baised eQTL |
| rs4237407 | chr10:9513687:T:C | - | 0.0699729104843666 | 0.042034951257499 | KIRC | Female-baised eQTL |
| rs112756695 | chr10:8232510:G:A | - | 0.182762749985465 | 0.00832624671164316 | BLCA | Female-baised eQTL |
| rs1926697 | chr10:22085560:G:A | - | 0.107770723213437 | 0.0151652649275199 | BLCA | Female-baised eQTL |
| rs60009316 | chr10:17429763:G:T | - | 0.142696282607681 | 0.0152139679944952 | BLCA | Female-baised eQTL |
| rs3011627 | chr10:22070969:A:G | - | -0.104751201704952 | 0.0218855410347655 | BLCA | Female-baised eQTL |
| rs3011636 | chr10:22075635:G:A | - | 0.104751201704952 | 0.0218855410347655 | BLCA | Female-baised eQTL |
| rs2986338 | chr10:22079429:G:C | - | 0.104751201704952 | 0.0218855410347655 | BLCA | Female-baised eQTL |
| rs2986333 | chr10:22089658:C:G | - | 0.104751201704952 | 0.0218855410347655 | BLCA | Female-baised eQTL |
| rs2986332 | chr10:22089701:G:A | - | 0.104751201704952 | 0.0218855410347655 | BLCA | Female-baised eQTL |
| rs2986331 | chr10:22089754:G:A | - | 0.104751201704952 | 0.0218855410347655 | BLCA | Female-baised eQTL |
| rs3011640 | chr10:22096295:C:A | - | 0.104751201704952 | 0.0218855410347655 | BLCA | Female-baised eQTL |
| rs7068065 | chr10:22046160:G:A | - | -0.104625188943756 | 0.022274633311901 | BLCA | Female-baised eQTL |
| rs61842123 | chr10:17391363:G:A | - | 0.135062711706325 | 0.0281211013507381 | BLCA | Female-baised eQTL |
| rs7090520 | chr10:22045703:C:T | - | -0.104264976279204 | 0.0284317146060443 | BLCA | Female-baised eQTL |
| rs45466899 | chr10:17398196:G:A | - | 0.135089461114537 | 0.0285010529114253 | BLCA | Female-baised eQTL |
| rs4437938 | chr10:22052492:G:A | - | -0.102060019043511 | 0.0293669170760357 | BLCA | Female-baised eQTL |
| rs11812907 | chr10:22053103:T:C | - | -0.102060019043511 | 0.0293669170760357 | BLCA | Female-baised eQTL |
| rs7897803 | chr10:22054340:G:T | - | -0.102060019043511 | 0.0293669170760357 | BLCA | Female-baised eQTL |
| rs10764335 | chr10:22054461:T:C | - | -0.102060019043511 | 0.0293669170760357 | BLCA | Female-baised eQTL |
| rs4592322 | chr10:22055238:A:G | - | -0.102060019043511 | 0.0293669170760357 | BLCA | Female-baised eQTL |
| rs10741000 | chr10:22055391:G:C | - | -0.102060019043511 | 0.0293669170760357 | BLCA | Female-baised eQTL |
| rs6482201 | chr10:22064023:T:C | - | -0.102060019043511 | 0.0293669170760357 | BLCA | Female-baised eQTL |
| rs11012883 | chr10:18179195:C:T | - | 0.227715442118055 | 0.0297204572639207 | BLCA | Female-baised eQTL |
| rs78940953 | chr10:18204666:G:C | - | 0.197093622245287 | 0.0304012473690825 | BLCA | Female-baised eQTL |
| rs6482198 | chr10:22047222:G:A | - | -0.101462344141962 | 0.0331396344348853 | BLCA | Female-baised eQTL |
| rs881774 | chr10:17438593:A:G | - | 0.143507611966136 | 0.0357538554604545 | BLCA | Female-baised eQTL |
| rs10508542 | chr10:17445329:A:G | - | 0.135791168526117 | 0.0367946551838272 | BLCA | Female-baised eQTL |
| rs7895707 | chr10:22049029:T:G | - | -0.100090269215907 | 0.0376498710602447 | BLCA | Female-baised eQTL |
| rs61564840 | chr10:17445664:G:C | - | 0.120749119415198 | 0.0389789244659179 | BLCA | Female-baised eQTL |
| rs1931881 | chr10:19316654:A:T | - | 0.0815758690026943 | 0.0399753785591101 | BLCA | Female-baised eQTL |
| rs6482200 | chr10:22063020:A:G | - | -0.100063338763941 | 0.0412717431394826 | BLCA | Female-baised eQTL |
| rs59320988 | chr10:17445901:G:A | - | 0.133795991590029 | 0.0425320640955351 | BLCA | Female-baised eQTL |
| rs746571 | chr10:17409325:G:A | - | 0.12851019307142 | 0.0442326021216239 | BLCA | Female-baised eQTL |
| rs913519 | chr10:17410488:A:C | - | 0.12851019307142 | 0.0442326021216239 | BLCA | Female-baised eQTL |
| rs1810796 | chr10:17411393:G:A | - | 0.12851019307142 | 0.0442326021216239 | BLCA | Female-baised eQTL |
| rs7095166 | chr10:7779118:A:G | - | -0.0922288593926218 | 0.0454127525893326 | BLCA | Female-baised eQTL |
| rs66745587 | chr10:17503893:C:T | - | 0.130305792770026 | 0.0454630399510144 | BLCA | Female-baised eQTL |
| rs45466893 | chr10:17422443:T:C | - | 0.128357200314794 | 0.0455735288770397 | BLCA | Female-baised eQTL |
| rs11257524 | chr10:12081081:A:G | - | 0.129114935571054 | 0.0457287409567828 | BLCA | Female-baised eQTL |
| rs4362054 | chr10:22027183:T:C | - | -0.0987988938776704 | 0.0461099239566449 | BLCA | Female-baised eQTL |
| rs3858190 | chr10:17498371:G:A | - | 0.127904816380714 | 0.0475052498663165 | BLCA | Female-baised eQTL |
| rs7098654 | chr10:7779230:A:G | - | -0.0944982525758564 | 0.0483303878968068 | BLCA | Female-baised eQTL |
| rs10740998 | chr10:22022376:T:C | - | -0.0987974613349469 | 0.0493916385493474 | BLCA | Female-baised eQTL |
| rs7898914 | chr10:22038392:A:G | - | -0.0983367809897782 | 0.0497458019424858 | BLCA | Female-baised eQTL |
| rs112255861 | chr10:8155975:G:A | - | 0.0714112650220381 | 0.0261273676451663 | LUAD | Female-baised eQTL |
| rs79328229 | chr10:8156227:C:T | - | 0.0714112650220381 | 0.0261273676451663 | LUAD | Female-baised eQTL |
| rs17448742 | chr10:8157028:A:T | - | 0.07030279576517 | 0.028199381495874 | LUAD | Female-baised eQTL |
| rs61835509 | chr10:8160286:C:A | - | 0.0698352361966203 | 0.0303785885564451 | LUAD | Female-baised eQTL |
| rs79694956 | chr10:8171758:C:T | - | 0.0703821962580914 | 0.0305587808088049 | LUAD | Female-baised eQTL |
| rs112591670 | chr10:8179695:C:T | - | 0.0716030287105046 | 0.0305729771057075 | LUAD | Female-baised eQTL |
| rs144959133 | chr10:8179727:C:T | - | 0.0716030287105046 | 0.0305729771057075 | LUAD | Female-baised eQTL |
| rs147950758 | chr10:8179728:G:A | - | 0.0716030287105046 | 0.0305729771057075 | LUAD | Female-baised eQTL |
| rs113147002 | chr10:8179767:A:C | - | 0.0716030287105046 | 0.0305729771057075 | LUAD | Female-baised eQTL |
| rs11595823 | chr10:8169544:A:G | - | 0.0703290504464511 | 0.0307989786364243 | LUAD | Female-baised eQTL |
| rs925308 | chr10:8170249:T:A | - | 0.0703290504464511 | 0.0307989786364243 | LUAD | Female-baised eQTL |
| rs79551343 | chr10:8153076:T:C | - | 0.068316624915552 | 0.0382387773335067 | LUAD | Female-baised eQTL |
| rs75445407 | chr10:8153281:A:T | - | 0.068316624915552 | 0.0382387773335067 | LUAD | Female-baised eQTL |
| rs112108577 | chr10:8153371:T:C | - | 0.068316624915552 | 0.0382387773335067 | LUAD | Female-baised eQTL |
| rs113004054 | chr10:8153953:G:C | - | 0.068316624915552 | 0.0382387773335067 | LUAD | Female-baised eQTL |
| rs17376570 | chr10:8153986:T:C | - | 0.068316624915552 | 0.0382387773335067 | LUAD | Female-baised eQTL |
| rs113460746 | chr10:8154390:G:A | - | 0.068316624915552 | 0.0382387773335067 | LUAD | Female-baised eQTL |
| rs374564896 | chr10:8154402:C:T | - | 0.068316624915552 | 0.0382387773335067 | LUAD | Female-baised eQTL |
| rs77991746 | chr10:8172742:C:T | - | 0.0681182125708374 | 0.0389383547193596 | LUAD | Female-baised eQTL |
| rs111235588 | chr10:8173004:G:T | - | 0.0681182125708374 | 0.0389383547193596 | LUAD | Female-baised eQTL |
| rs77603728 | chr10:8173568:C:G | - | 0.0681182125708374 | 0.0389383547193596 | LUAD | Female-baised eQTL |
| rs11599087 | chr10:8174749:A:T | - | 0.0678603885860357 | 0.0402659196840415 | LUAD | Female-baised eQTL |
| rs4749660 | chr10:8151427:G:A | - | 0.0685062207106803 | 0.0403598978630041 | LUAD | Female-baised eQTL |
| rs11592333 | chr10:8152143:T:C | - | 0.0685062207106803 | 0.0403598978630041 | LUAD | Female-baised eQTL |
| rs4747749 | chr10:8178921:A:G | - | 0.068930837174127 | 0.0411278731582074 | LUAD | Female-baised eQTL |
| rs113839996 | chr10:8179835:T:C | - | 0.068930837174127 | 0.0411278731582074 | LUAD | Female-baised eQTL |
| rs113162215 | chr10:8179870:A:T | - | 0.068930837174127 | 0.0411278731582074 | LUAD | Female-baised eQTL |
| rs113697874 | chr10:8180085:G:A | - | 0.068930837174127 | 0.0411278731582074 | LUAD | Female-baised eQTL |
| rs113676121 | chr10:8160933:C:T | - | 0.0677249608820196 | 0.041447754890811 | LUAD | Female-baised eQTL |
| rs78683697 | chr10:8162316:G:T | - | 0.0677249608820196 | 0.041447754890811 | LUAD | Female-baised eQTL |
| rs113197820 | chr10:8163185:C:T | - | 0.0681756932592613 | 0.0421149868140583 | LUAD | Female-baised eQTL |
| rs78238050 | chr10:8163487:G:C | - | 0.0681756932592613 | 0.0421149868140583 | LUAD | Female-baised eQTL |
| rs17449373 | chr10:8164643:T:C | - | 0.0681756932592613 | 0.0421149868140583 | LUAD | Female-baised eQTL |
| rs4749667 | chr10:8167742:C:T | - | 0.0681756932592613 | 0.0421149868140583 | LUAD | Female-baised eQTL |
| rs4749673 | chr10:8177421:A:G | - | 0.0687057071085509 | 0.042299374019736 | LUAD | Female-baised eQTL |
| rs4749674 | chr10:8177451:T:C | - | 0.0687057071085509 | 0.042299374019736 | LUAD | Female-baised eQTL |
| rs4749675 | chr10:8177525:T:C | - | 0.0687057071085509 | 0.042299374019736 | LUAD | Female-baised eQTL |
| rs1509968 | chr10:8181117:C:T | - | 0.0680806931758189 | 0.0426908413836883 | LUAD | Female-baised eQTL |
| rs17450067 | chr10:8182228:G:A | - | 0.0680806931758189 | 0.0426908413836883 | LUAD | Female-baised eQTL |
| rs17450095 | chr10:8182298:T:G | - | 0.0680806931758189 | 0.0426908413836883 | LUAD | Female-baised eQTL |
| rs4749680 | chr10:8182141:A:C | - | 0.0662932300000344 | 0.0442218652793137 | LUAD | Female-baised eQTL |
| rs4749677 | chr10:8178351:C:A | - | 0.0683629578169782 | 0.0445058442426436 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs80254498 | chr10:25628569:C:T | - | 0.0628561235430284 | 0.00168824896738169 | BLCA | Male-baised eQTL |
| rs117321015 | chr10:25628340:A:T | - | 0.0606551721456281 | 0.00257996423457458 | BLCA | Male-baised eQTL |
| rs117120455 | chr10:25620860:C:T | - | 0.0485836646856045 | 0.0230830485851794 | BLCA | Male-baised eQTL |
| rs146494715 | chr10:25620970:G:T | - | 0.0485836646856045 | 0.0230830485851794 | BLCA | Male-baised eQTL |
| rs5003418 | chr10:16153168:C:T | - | 0.048658707077522 | 0.0201547343879843 | LUAD | Male-baised eQTL |
| rs1953955 | chr10:16153352:A:T | - | 0.048658707077522 | 0.0201547343879843 | LUAD | Male-baised eQTL |
| rs61841846 | chr10:16152091:A:G | - | 0.0486965815763945 | 0.020362393080065 | LUAD | Male-baised eQTL |
| rs12359117 | chr10:16152159:A:G | - | 0.0486965815763945 | 0.020362393080065 | LUAD | Male-baised eQTL |
| rs11253827 | chr10:16156731:T:C | - | 0.0485269464426021 | 0.0214625358968056 | LUAD | Male-baised eQTL |
| rs2226024 | chr10:16156981:A:G | - | 0.0479667117787074 | 0.0243959911525797 | LUAD | Male-baised eQTL |
| rs1953954 | chr10:16153449:G:A | - | 0.0464115573963089 | 0.0320297212134752 | LUAD | Male-baised eQTL |
| rs11253826 | chr10:16156011:G:T | - | 0.0458974265046622 | 0.0369024789738732 | LUAD | Male-baised eQTL |
| rs12357014 | chr10:16154260:G:A | - | 0.0443958004421007 | 0.0478700049116434 | LUAD | Male-baised eQTL |
| rs12358557 | chr10:16154269:T:C | - | 0.0443958004421007 | 0.0478700049116434 | LUAD | Male-baised eQTL |
| rs12357007 | chr10:16154323:C:T | - | 0.0443958004421007 | 0.0478700049116434 | LUAD | Male-baised eQTL |
| rs61841847 | chr10:16155207:C:G | - | 0.0443958004421007 | 0.0478700049116434 | LUAD | Male-baised eQTL |
| rs11253822 | chr10:16155268:C:A | - | 0.0443958004421007 | 0.0478700049116434 | LUAD | Male-baised eQTL |
| rs11253823 | chr10:16155434:T:C | - | 0.0443958004421007 | 0.0478700049116434 | LUAD | Male-baised eQTL |
| rs11253824 | chr10:16155449:C:G | - | 0.0443958004421007 | 0.0478700049116434 | LUAD | Male-baised eQTL |
| rs41382649 | chr10:7641910:A:T | - | 0.0959452328662758 | 9.58666098245137e-05 | COAD | Male-baised eQTL |
| rs2497800 | chr10:18062132:C:T | - | 0.137292977241802 | 0.000933051524520989 | COAD | Male-baised eQTL |
| rs2488156 | chr10:18072466:C:T | - | 0.134682111700261 | 0.00131350714099399 | COAD | Male-baised eQTL |
| rs2497804 | chr10:18065198:T:C | - | 0.131466877344246 | 0.00167459254872609 | COAD | Male-baised eQTL |
| rs2497812 | chr10:18072908:G:A | - | 0.129187397312201 | 0.00227962442060423 | COAD | Male-baised eQTL |
| rs2497808 | chr10:18069674:G:A | - | 0.123967023810643 | 0.00375424461411621 | COAD | Male-baised eQTL |
| rs2497809 | chr10:18071315:A:G | - | 0.123967023810643 | 0.00375424461411621 | COAD | Male-baised eQTL |
| rs2497810 | chr10:18071575:C:G | - | 0.123967023810643 | 0.00375424461411621 | COAD | Male-baised eQTL |
| rs2497813 | chr10:18073056:A:G | - | 0.121412819151221 | 0.00516045114776712 | COAD | Male-baised eQTL |
| rs17327001 | chr10:14184653:G:A | - | 0.0721677756326056 | 0.0104929519687576 | COAD | Male-baised eQTL |
| rs1150029 | chr10:9322954:T:C | - | 0.0541340734493733 | 0.0174123008906132 | COAD | Male-baised eQTL |
| rs1150036 | chr10:9327350:A:G | - | 0.0541340734493733 | 0.0174123008906132 | COAD | Male-baised eQTL |
| rs827916 | chr10:9344110:C:T | - | -0.0555454382972863 | 0.0199959898791715 | COAD | Male-baised eQTL |
| rs10905540 | chr10:9342554:G:A | - | 0.0534291285256062 | 0.0209775802017265 | COAD | Male-baised eQTL |
| rs1150047 | chr10:9337629:C:T | - | 0.0533869643950166 | 0.0237368163091784 | COAD | Male-baised eQTL |
| rs17156739 | chr10:15470601:A:G | - | 0.103275628183116 | 0.0241947394775632 | COAD | Male-baised eQTL |
| rs1150034 | chr10:9326916:T:C | - | 0.0524520873016784 | 0.0282892432960224 | COAD | Male-baised eQTL |
| rs11257831 | chr10:12497233:C:G | - | 0.0590151244472509 | 0.0310228222935673 | COAD | Male-baised eQTL |
| rs12784757 | chr10:9404250:C:T | - | -0.0542791653558395 | 0.0311144599102697 | COAD | Male-baised eQTL |
| rs1150044 | chr10:9334013:G:A | - | 0.0518544100107557 | 0.0339293780568476 | COAD | Male-baised eQTL |
| rs1150028 | chr10:9322437:A:G | - | 0.0511588335277703 | 0.0346216283508323 | COAD | Male-baised eQTL |
| rs1150031 | chr10:9323511:C:A | - | 0.0511588335277703 | 0.0346216283508323 | COAD | Male-baised eQTL |
| rs12784138 | chr10:9339689:G:A | - | -0.0504642729309568 | 0.0352262806990143 | COAD | Male-baised eQTL |
| rs2484330 | chr10:9340207:G:A | - | -0.0504642729309568 | 0.0352262806990143 | COAD | Male-baised eQTL |
| rs11256177 | chr10:9384832:G:C | - | 0.05277044011913 | 0.0353986921758873 | COAD | Male-baised eQTL |
| rs2488159 | chr10:18082062:G:A | - | 0.0946888602359124 | 0.0361589161114073 | COAD | Male-baised eQTL |
| rs2497819 | chr10:18078918:A:C | - | 0.0941148185951299 | 0.0378643841718045 | COAD | Male-baised eQTL |
| rs7078980 | chr10:12496492:G:A | - | 0.0565904180983798 | 0.0408720555178504 | COAD | Male-baised eQTL |
| rs2497822 | chr10:18081041:A:G | - | 0.0940780149851105 | 0.0409488910938769 | COAD | Male-baised eQTL |
| rs1591408 | chr10:9340895:A:G | - | -0.0491944799551752 | 0.0417089798325487 | COAD | Male-baised eQTL |
| rs933079 | chr10:9399855:A:G | - | 0.0521875265684799 | 0.0426948126381952 | COAD | Male-baised eQTL |
| rs1242970 | chr10:9210098:C:T | - | 0.0635575857311351 | 0.0435176353557244 | COAD | Male-baised eQTL |
| rs12218720 | chr10:9383565:A:C | - | 0.0514503917702202 | 0.0447684358666837 | COAD | Male-baised eQTL |
| rs10905547 | chr10:9384563:A:G | - | 0.0514503917702202 | 0.0447684358666837 | COAD | Male-baised eQTL |
| rs7095896 | chr10:14188930:G:C | - | 0.0591850081884034 | 0.0447771382267354 | COAD | Male-baised eQTL |
| rs1150027 | chr10:9321488:G:A | - | 0.04970287814762 | 0.0461197366797272 | COAD | Male-baised eQTL |
| rs11259118 | chr10:14465884:A:C | - | 0.0973997033909484 | 0.0464019155334067 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of VIM |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000026025 | VIM | C0006142 | Malignant neoplasm of breast | 4 | CTD_human |
| ENSG00000026025 | VIM | C0007140 | Carcinosarcoma | 1 | CTD_human |
| ENSG00000026025 | VIM | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
| ENSG00000026025 | VIM | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
| ENSG00000026025 | VIM | C0023890 | Liver Cirrhosis | 2 | CTD_human |
| ENSG00000026025 | VIM | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| ENSG00000026025 | VIM | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
| ENSG00000026025 | VIM | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
| ENSG00000026025 | VIM | C0027720 | Nephrosis | 1 | CTD_human |
| ENSG00000026025 | VIM | C0029408 | Degenerative polyarthritis | 2 | CTD_human |
| ENSG00000026025 | VIM | C0031149 | Peritoneal Neoplasms | 1 | CTD_human |
| ENSG00000026025 | VIM | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
| ENSG00000026025 | VIM | C0035126 | Reperfusion Injury | 1 | CTD_human |
| ENSG00000026025 | VIM | C0035309 | Retinal Diseases | 1 | CTD_human |
| ENSG00000026025 | VIM | C0039101 | synovial sarcoma | 1 | CTD_human |
| ENSG00000026025 | VIM | C0043094 | Weight Gain | 1 | CTD_human |
| ENSG00000026025 | VIM | C0085084 | Motor Neuron Disease | 1 | CTD_human |
| ENSG00000026025 | VIM | C0086543 | Cataract | 1 | CTD_human |
| ENSG00000026025 | VIM | C0086743 | Osteoarthrosis Deformans | 2 | CTD_human |
| ENSG00000026025 | VIM | C0154681 | Anterior Horn Cell Disease | 1 | CTD_human |
| ENSG00000026025 | VIM | C0154682 | Lateral Sclerosis | 1 | CTD_human |
| ENSG00000026025 | VIM | C0239946 | Fibrosis, Liver | 2 | CTD_human |
| ENSG00000026025 | VIM | C0270715 | Degenerative Diseases, Central Nervous System | 1 | CTD_human |
| ENSG00000026025 | VIM | C0270763 | Familial Motor Neuron Disease | 1 | CTD_human |
| ENSG00000026025 | VIM | C0270764 | Motor Neuron Disease, Lower | 1 | CTD_human |
| ENSG00000026025 | VIM | C0345967 | Malignant mesothelioma | 1 | CTD_human |
| ENSG00000026025 | VIM | C0346990 | Carcinomatosis of peritoneal cavity | 1 | CTD_human |
| ENSG00000026025 | VIM | C0376358 | Malignant neoplasm of prostate | 2 | CTD_human |
| ENSG00000026025 | VIM | C0521659 | Motor Neuron Disease, Upper | 1 | CTD_human |
| ENSG00000026025 | VIM | C0524524 | Pseudoaphakia | 1 | CTD_human |
| ENSG00000026025 | VIM | C0524851 | Neurodegenerative Disorders | 1 | CTD_human |
| ENSG00000026025 | VIM | C0543858 | Motor Neuron Disease, Secondary | 1 | CTD_human |
| ENSG00000026025 | VIM | C0678222 | Breast Carcinoma | 4 | CTD_human |
| ENSG00000026025 | VIM | C0751733 | Degenerative Diseases, Spinal Cord | 1 | CTD_human |
| ENSG00000026025 | VIM | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
| ENSG00000026025 | VIM | C0948089 | Acute Coronary Syndrome | 1 | CTD_human |
| ENSG00000026025 | VIM | C1257931 | Mammary Neoplasms, Human | 4 | CTD_human |
| ENSG00000026025 | VIM | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
| ENSG00000026025 | VIM | C1458155 | Mammary Neoplasms | 4 | CTD_human |
| ENSG00000026025 | VIM | C1510497 | Lens Opacities | 1 | CTD_human |
| ENSG00000026025 | VIM | C1861827 | Cataract, Nuclear Diffuse Nonprogressive | 1 | CTD_human |
| ENSG00000026025 | VIM | C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1 | CTD_human |
| ENSG00000026025 | VIM | C1862941 | Amyotrophic Lateral Sclerosis, Sporadic | 1 | CTD_human |
| ENSG00000026025 | VIM | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
| ENSG00000026025 | VIM | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
| ENSG00000026025 | VIM | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
| ENSG00000026025 | VIM | C4551993 | Amyotrophic Lateral Sclerosis, Familial | 1 | CTD_human |
| ENSG00000026025 | VIM | C4704874 | Mammary Carcinoma, Human | 4 | CTD_human |
